These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30556332)

  • 1. Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel.
    Yuen F; Wu S; Thirumalai A; Swerdloff RS; Page ST; Liu PY; Dart C; Wu H; Blithe DL; Sitruk-Ware R; Long J; Bai F; Hull L; Bremner WJ; Anawalt BD; Wang C
    Andrology; 2019 Mar; 7(2):235-243. PubMed ID: 30556332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.
    Anawalt BD; Roth MY; Ceponis J; Surampudi V; Amory JK; Swerdloff RS; Liu PY; Dart C; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Page ST; Wang C
    Andrology; 2019 Nov; 7(6):878-887. PubMed ID: 30969032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
    Mahabadi V; Amory JK; Swerdloff RS; Bremner WJ; Page ST; Sitruk-Ware R; Christensen PD; Kumar N; Tsong YY; Blithe D; Wang C
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2313-20. PubMed ID: 19366848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.
    Ilani N; Roth MY; Amory JK; Swerdloff RS; Dart C; Page ST; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Wang C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3476-86. PubMed ID: 22791756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel.
    Stahlman J; Britto M; Fitzpatrick S; McWhirter C; Testino SA; Brennan JJ; Zumbrunnen TL
    Curr Med Res Opin; 2012 Feb; 28(2):281-90. PubMed ID: 22188557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum testosterone levels in non-dosed females after secondary exposure to 1.62% testosterone gel: effects of clothing barrier on testosterone absorption.
    Stahlman J; Britto M; Fitzpatrick S; McWhirter C; Testino SA; Brennan JJ; Zumbrunnen TL
    Curr Med Res Opin; 2012 Feb; 28(2):291-301. PubMed ID: 22188558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.
    Roth MY; Shih G; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Sitruk-Ware R; Blithe DL; Amory JK
    Contraception; 2014 Oct; 90(4):407-12. PubMed ID: 24981149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial.
    Zitzmann M; Rohayem J; Raidt J; Kliesch S; Kumar N; Sitruk-Ware R; Nieschlag E
    Andrology; 2017 May; 5(3):516-526. PubMed ID: 28189123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women.
    Brache V; Merkatz R; Kumar N; Jesam C; Sussman H; Hoskin E; Roberts K; Alami M; Taylor D; Jorge A; Croxatto H; Lorange E; Mishell DR; Sitruk-Ware R
    Contraception; 2015 Oct; 92(4):289-97. PubMed ID: 26032952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.
    Roth MY; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Dart C; Sitruk-Ware R; Kumar N; Blithe D; Amory JK
    Andrology; 2013 Nov; 1(6):899-905. PubMed ID: 24123845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
    Jensen JT; Edelman AB; Chen BA; Archer DF; Barnhart KT; Thomas MA; Burke AE; Westhoff CL; Wan LS; Sitruk-Ware R; Kumar N; Variano B; Blithe DL
    Contraception; 2018 May; 97(5):422-427. PubMed ID: 29409834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
    Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
    J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone).
    Amory JK; Blithe DL; Sitruk-Ware R; Swerdloff RS; Bremner WJ; Dart C; Liu PY; Thirumalai A; Nguyen BT; Anawalt BD; Lee MS; Page ST; Wang C
    Contraception; 2023 Aug; 124():110064. PubMed ID: 37210024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous assay of segesterone acetate (Nestorone®), estradiol, progesterone, and estrone in human serum by LC-MS/MS.
    Erikson DW; Blue SW; Fecteau KM; Edelman AB; Jensen JT; Blithe DL
    Contraception; 2020 Nov; 102(5):361-367. PubMed ID: 32828731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.
    Fraser IS; Weisberg E; Kumar N; Kumar S; Humberstone AJ; McCrossin L; Shaw D; Tsong YY; Sitruk-Ware R
    Contraception; 2007 Dec; 76(6):432-8. PubMed ID: 18061700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference.
    Dmochowski RR; Newman DK; Sand PK; Rudy DC; Caramelli KE; Thomas H; Hoel G
    Clin Drug Investig; 2011; 31(8):559-571. PubMed ID: 21721591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
    Fraser IS; Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Tsong YY; Sivin I
    Contraception; 2005 Jul; 72(1):40-5. PubMed ID: 15964291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of skin washing on systemic absorption of testosterone in hypogonadal males after administration of 1.62% testosterone gel.
    Stahlman J; Britto M; Fitzpatrick S; McWhirter C; Testino SA; Brennan JJ; Zumbrunnen TL
    Curr Med Res Opin; 2012 Feb; 28(2):271-9. PubMed ID: 22185431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of transdermally applied testosterone to clothing: a comparison of a testosterone patch versus a testosterone gel.
    Mazer N; Fisher D; Fischer J; Cosgrove M; Bell D; Eilers B
    J Sex Med; 2005 Mar; 2(2):227-34. PubMed ID: 16422890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.